Effects of Respiratory Rehabilitation on ICU Patients

December 14, 2020 updated by: wang kaifei, Chinese PLA General Hospital

Effects of Respiratory Rehabilitation on Patients After Extubation

Effects of respiratory rehabilitation on patients after extubation

Study Overview

Status

Unknown

Detailed Description

The purpose of this study is to evaluate whether sequential treatment with high-flow humidification therapy apparatus can improve the postoperative recovery and functional status of patients with invasive mechanical ventilation in ICU after the withdrawal of the catheter.Inclusion criteria: age 18-95;The hemodynamics were stable, that is, 50 < heart rate less than 120 beats/min, 90 < systolic blood pressure < 200mmHg, 55 < mean arterial pressure < 120mmHg.Do not increase the dose of vasopressor for at least 2 hours;Intracranial pressure was stable and there was no seizure within 24 hours.The breathing condition was stable, that is, the oxygen satiety of the patient's finger vein was ≥88%, and the breathing frequency was >10 and< 35 times/min.Exclusion criteria: pregnancy;Acute myocardial infarction.A total of 50 patients who are sequentially treated with high-flow humidification therapy apparatus after extubation in ICU are randomly assigned. The experimental group receive respiratory rehabilitation therapy, while the control group only receive routine medical treatment. All the enrolled patients underwent rehabilitation evaluation and bedside diaphragmatic ultrasound measurement.This study was approved by the Ethics Committee of the CPLA General Hospital (project No.2018-212-01). The following clinical datas were recorded for all patients through the unified database software: The rehabilitation program was formulated according to the cluster management strategy of ABCDEF and the six-step method of early activities.All of the patients in monitoring vital signs, every day at hospital group and all peripheral muscle MRC assessment, 30 s sit stand trial, modified Barthel index, Borg dyspnea score, arterial blood gas analysis, diaphragm ultrasonic monitoring by the bed, finally the experimental process on the patients whether using noninvasive ventilator, whether for endotracheal intubation again, whether to have new complications (pressure sores, aspiration, thrombosis, etc.) and the patients bed time statistics for the first time. Statistical analyses were conducted by SPSS 21.0 and a two-tailed P < 0.05 was considered significant.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged above 18
  • The hemodynamics are stable
  • 50 < heart rate less than 120 beats/min
  • 90 < systolic blood pressure < 200mmHg
  • 55 < mean arterial pressure < 120mmHg
  • Do not increase the dose of vasopressor for at least 2 hours
  • Intracranial pressure was stable and there is no seizure within 24 hours
  • The breathing condition is stable
  • the oxygen satiety of the patient's finger vein is ≥88%
  • 10<the breathing frequency < 35 times/min

Exclusion Criteria:

  • Pregnancy
  • Acute myocardial infarction (ami)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rehabilitation group
To conduct a comprehensive pulmonary rehabilitation assessment and treatment
Pulmonary rehabilitation (respiratory rehabilitation) is a comprehensive intervention based on a comprehensive patient assessment, targeted to the treatment of patients, including but not limited to exercise training, education and behavior change, aimed at improving the physical and mental health of patients with chronic respiratory diseases and promoting long-term adherence to health-enhancing behaviors.
No Intervention: Conventional medical group
Conventional medical treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reintubation rates
Time Frame: 28 days
The artificial airway was established again for invasive mechanical ventilation
28 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRC,medical research council
Time Frame: 28 days
medical research council,Assessment of peripheral muscle strength,total points0~60,less than 48scores means ICU aquired weaknesses.
28 days
30-STS
Time Frame: 28 days
30 second sit-to-stand test.The more times, has the better muscular endurance.
28 days
Barthel
Time Frame: 28 days
Assessment of activities of daily living.total points0~100,less than 60 scores means can't independent living.
28 days
Borg dyspnea score
Time Frame: 28 days
total points0~10,The higher the grade, the more difficulty breathing.
28 days
oxygen partial pressure
Time Frame: 28 days
Partial pressure of oxygen in arterial blood,normal range is 80~100.
28 days
oxygenation index
Time Frame: 28 days
The partial pressure of oxygen divided by the concentration of oxygen,Normal is greater than 400.
28 days
The diaphragmatic excursion
Time Frame: 28 days
The distance the diaphragm moves up and down during breathing,normal is 1.4cm.
28 days
diaphragm contraction rate
Time Frame: 28 days
The rate at which the diaphragm contracts during breathing,normal is 1.3cm/s.
28 days
diaphragm thickness diaphragm thickness fraction
Time Frame: 28 days
Thickness of diaphragm during breathing,(Diaphragm thickness at the end of inhalation-Diaphragm thickness at the end of exhalation)/Diaphragm thickness at the end of exhalation
28 days
length of stay in ICU
Time Frame: three months
Length of stay in ICU
three months
LOS(length of stay)
Time Frame: three months
length of stay in hospital
three months
First time out of bed
Time Frame: three months
First time out of bed by oneself
three months
Noninvasive utilization rate
Time Frame: 28 days
Non-invasive ventilator usage
28 days
mortality
Time Frame: 28 days
Alive or Dead
28 days
Complication rate
Time Frame: 28 days
The incidence of new complications(pressure sores、thrombus、aspiration)
28 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: xin li xie, Ph.D., Study Principal Investigator Chinese PLA General Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 20, 2020

Primary Completion (Anticipated)

April 20, 2021

Study Completion (Anticipated)

April 20, 2021

Study Registration Dates

First Submitted

April 22, 2020

First Submitted That Met QC Criteria

April 27, 2020

First Posted (Actual)

April 29, 2020

Study Record Updates

Last Update Posted (Actual)

December 16, 2020

Last Update Submitted That Met QC Criteria

December 14, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • S2018-212-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on pulmonary rehabilitation

3
Subscribe